Medicare Enrolled

Dr. Gregory Hanes, MD

Neurology · Sarasota, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
1921 WALDEMERE, Sarasota, FL 34239
9414872160
In practice since 2006 (19 years)
NPI: 1255342994 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hanes from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hanes? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hanes

Dr. Gregory Hanes is a neurology specialist in Sarasota, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hanes performed 54,242 Medicare services across 1,446 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hanes received a total of $232,075 from 69 pharmaceutical and/or device companies across 773 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hanes is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 1% volume in FL $232,075 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 88942 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
54,242
Medicare services
Top 1% in FL for neurology
1,446
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,855 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
52,500 $5 $10
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
346 $92 $219
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
313 $62 $151
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
212 $72 $225
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
118 $117 $306
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 98 $58 $148
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
70 $119 $333
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
67 $128 $415
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
50 $61 $148
Chemical nerve block for neck muscles
Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box.
48 $155 $260
New patient office visit, complex (60-74 min) 48 $168 $421
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
46 $98 $283
Chemical nerve block for facial paralysis
Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face.
45 $103 $344
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
37 $179 $523
Chemical nerve block injection, 5+ arm/leg muscles
Injection of a chemical agent to paralyze five or more muscles in the first extremity treated.
32 $137 $328
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
32 $94 $213
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
31 $41 $118
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
27 $131 $394
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
27 $152 $470
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
24 $216 $603
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
23 $96 $299
Limited needle EMG of arm or leg muscles
A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area.
20 $47 $150
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
16 $170 $570
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
12 $129 $294
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$232,075
Total received (2018-2024)
Avg $33,154/year across 7 years
Top 3% in FL for neurology
69
Companies
773
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$207,022 (89.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$15,198 (6.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,855 (4.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$40,987
2023
$22,242
2022
$26,089
2021
$42,594
2020
$33,343
2019
$55,760
2018
$11,059

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Allergan, Inc.
$83,479
ABBVIE INC.
$73,235
Allergan Inc.
$51,799
AbbVie Inc.
$7,742
ARGENX US, INC.
$3,261
CATALYST PHARMACEUTICALS, INC.
$1,765
Janssen Research & Development, LLC
$924
Grifols USA, LLC
$904
UCB, Inc.
$710
Alexion Pharmaceuticals, Inc.
$671
Teva Pharmaceuticals USA, Inc.
$586
Acorda Therapeutics, Inc
$498
Sunovion Pharmaceuticals Inc.
$460
Amgen Inc.
$459
Neurocrine Biosciences, Inc.
$320
CSL Behring
$315
Takeda Pharmaceuticals U.S.A., Inc.
$295
Eisai Inc.
$268
ACADIA Pharmaceuticals Inc
$249
Novartis Pharmaceuticals Corporation
$241
GE HealthCare
$237
SK Life Science, Inc.
$232
PORTOLA PHARMACEUTICALS, INC.
$213
Amneal Pharmaceuticals LLC
$202
Biogen, Inc.
$192
PFIZER INC.
$191
US WorldMeds, LLC
$181
Lundbeck LLC
$176
Alnylam Pharmaceuticals Inc.
$167
Adamas Pharmaceuticals, Inc.
$154
Neurelis, Inc.
$135
Avanir Pharmaceuticals, Inc.
$126
Greenwich Biosciences, Inc.
$119
Kyowa Kirin, Inc.
$100
Mitsubishi Tanabe Pharma America, Inc.
$98
Lilly USA, LLC
$98
Biohaven Pharmaceutical Holding Company Ltd.
$93
AstraZeneca Pharmaceuticals LP
$86
Supernus Pharmaceuticals, Inc.
$85
Otsuka America Pharmaceutical, Inc.
$73
Biohaven Pharmaceuticals, Inc.
$57
MITSUBISHI TANABE PHARMA AMERICA, INC.
$56
Akcea Therapeutics, Inc.
$53
Corium, LLC
$53
Ultragenyx Pharmaceutical Inc.
$47
Horizon Therapeutics plc
$46
Merz Pharmaceuticals, LLC
$46
GE HEALTHCARE
$46
ARBOR PHARMACEUTICALS, INC.
$42
Sumitomo Pharma America, Inc.
$40
EISAI INC.
$36
Avion Pharmaceuticals
$35
Amylyx Pharmaceuticals, Inc.
$34
Strongbridge US INC.
$32
GE Healthcare
$32
ASSERTIO THERAPEUTICS, Inc.
$31
Stryker Corporation
$28
Boston Scientific Corporation
$25
Bausch Health US, LLC
$24
AbbVie, Inc.
$23
Mallinckrodt LLC
$22
Bayer HealthCare Pharmaceuticals Inc.
$20
Azurity Pharmaceuticals, Inc.
$19
Assertio Therapeutics, Inc.
$18
Xeris Pharmaceuticals, Inc.
$15
Impax Laboratories, Inc.
$15
Zyla Life Sciences, Inc.
$15
Genentech USA, Inc.
$14
GRT US Holding, Inc.
$13
Top 3 companies account for 89.8% of total payments
Associated products mentioned in payments ›
ADUHELM · AGAMREE · AIMOVIG · AJOVY · AMYVID · ANDEXXA · APOKYN · APTIOM · AUSTEDO · Adlarity · Aimovig · Austedo XR · BEVYXXA · BOTOX · BOTOX COSMETIC · BOTOX THERAPEUTIC · BRILINTA · Betaseron · Briviact · COPAXONE · CREXONT · DUOPA · Dhivy · Duopa · EMGALITY · EPRONTIA · Epidiolex · FIRDAPSE · Fintepla · Fycompa · GAMMAGARD · GILENYA · GIVLAARI · GOCOVRI · Gamunex-C · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KEVEYIS · KYNMOBI · LYRICA · Leqembi · MIGRANAL · NAMZARIC · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFIRMEV · ONGENTYS · ONPATTRO · OXTELLAR XR · Ongentys · QULIPTA · Qutenza · RADICAVA · RELYVRIO · REXULTI · RYTARY · Radicava · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · Soliris · TEGSEDI · TREVO · TROKENDI XR · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XCOPRI · Xadago · Xeomin · Zilbrysq · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for neurology in FL.

Equivalent to $428 per 100 Medicare services performed
Looking for a neurology specialist in Sarasota?
Compare neurologists in the Sarasota area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
37
Per 100K population
8.2
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Hanes is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), with speaking/promotional industry engagement in the top 3% of FL peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Hanes experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Hanes performed 52,500 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hanes receive payments from pharmaceutical companies?
Yes. Dr. Hanes received a total of $232,075 from 69 companies across 773 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hanes's costs compare to other neurologists in Sarasota?
Dr. Hanes's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hanes) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →